Sechat - Notícias sobre a cannabis medicinal e cânhamo industrial

Featuring Larissa Meneghel (lawyer and former Anvisa public servant), Paula Scanapieco (Mile Express), and Juliana Sousa (lawyer specialized in customs and criminal law)

STJ Minister demands Union and Anvisa to execute the Action Plan for the medicinal cultivation of the plant

Experts analyze the scenario and highlight that the measure meets Anvisa's expectations for the Brazilian market; Analysis reveals that the new legislation does not represent prohibition, but rather a restructuring of the sector focusing on taxation and pharmaceutical control

Minister Regina Helena Costa states that this will be the last extension and orders Anvisa to report compliance with each intermediate step of the plan

Company demands urgent measures in face of new missed deadlines by the government and Anvisa and proposes experimental environment under judicial supervision

The use of medicinal cannabis in pets has been growing in Brazil since Anvisa's authorization in 2024, bringing relief for chronic pain, epilepsy, and anxiety in animals, and renewed hope for pet owners

COFFITO Ruling No. 735/2024 authorizes physical therapists with specific training to prescribe medications and supplies; however, Anvisa recognizes only doctors and dentists as prescribers of cannabis for medicinal purposes

Brazilian delegation led by Abiquifi participates in a mission to Colombia to exchange experiences on the regulation of cannabis cultivation, with representatives from MAPA, Anvisa, Embrapa, and major pharmaceutical industries

Expansion of the institute in the sector, however, depends on new authorizations from Anvisa for the quality control of plant-based raw materials

Studies show efficacy of cannabinoids in controlling inflammation, acne, and itching, while Anvisa evaluates expanding regulations for topical products

On Deusa Cast, lawyer Larissa Meneghel details how the five-year deadline set forth in RDC-327 for clinical cannabis research works and comments on the renewal proposal under review by Anvisa

Follow the instructions to initiate the import process through RDC 660

Regulatory advances expand access to cannabis treatments for animals, but veterinarians still face barriers in prescribing and regulating products

Understand the step-by-step process to acquire plant derivatives for medicinal purposes

With the revision of RDC 327/2019, compounding pharmacies gain space in the discussion on medicinal cannabis

In Deusa Cast #46, experts like Jaime Ozi analyze the obstacles preventing Brazil from advancing in cannabis regulation and highlight the impact of lack of research, medical education, and access

The safety and efficacy of cannabis-based products depend on an integrated chain involving chemists, biomedicals, pharmacists, and doctors — professionals who ensure, at each stage, the quality, stability, and trust in patient treatment

The new deadline extends the time for the government to finalize the regulation of cannabis cultivation for the production of medicines in the country

São Paulo hosts, on Thursday (06), the main meeting point for the Medicinal and Industrial Cannabis industry in Latin America

First Section's trial will take place on Thursday (06); decision impacts cannabis regulation in the country